Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth

BMC Pregnancy and Childbirth

Volumn 15, Issue 1, 2015, Pages

  Ciesielski, Timothy H ^a,b   Marsit, Carmen J ^a   Williams, Scott M ^a,b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; LEPTIN RECEPTOR;

ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DELIVERY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA METHYLATION; DRUG USE; EPIGENETICS; FEMALE; FETUS; FETUS GROWTH; GENE LOCUS; GENETIC VARIABILITY; GESTATION PERIOD; GROWTH DISORDER; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRENATAL PERIOD; SMALL FOR DATE INFANT; SYMPTOM; TRANSCRIPTION INITIATION SITE; UNITED STATES; VALIDATION STUDY; YOUNG ADULT; ANXIETY DISORDER; COMPLICATION; FETAL GROWTH RETARDATION; GENETIC EPIGENESIS; GENETICS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; NEWBORN; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PSYCHOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; DEPRESSIVE DISORDER; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, LEPTIN;

EID: 84939797798     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-015-0627-8     Document Type: Article

References (51)

1. Szegda K, Markenson G, Bertone-Johnson ER, Chasan-Taber L. Depression during pregnancy: a risk factor for adverse neonatal outcomes? A critical review of the literature. J Matern Fetal Neonatal Med. 2014;27(9):960-7.
2. Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e321-41.
3. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiatry. 2010;67(10):1012-24.
4. Lee HC, Lin HC. Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. J Affect Disord. 2010;121(1-2):100-5.
5. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry. 2005;162(1):79-91.
6. Warren SL, Racu C, Gregg V, Simmens SJ. Maternal panic disorder: Infant prematurity and low birth weight. J Anxiety Disord. 2006;20(3):342-52.
7. Banhidy F, Acs N, Puho E, Czeizel AE. Association between maternal panic disorders and pregnancy complications and delivery outcomes. Eur J Obstet Gynecol Reprod Biol. 2006;124(1):47-52.
8. Hironaka M, Kotani T, Sumigama S, Tsuda H, Mano Y, Hayakawa H, et al. Maternal mental disorders and pregnancy outcomes: a clinical study in a Japanese population. J Obstet Gynaecol Res. 2011;37(10):1283-9.
9. Wadhwa PD, Sandman CA, Porto M, Dunkel-Schetter C, Garite TJ. The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol. 1993;169(4):858-65.
10. Dejin-Karlsson E, Hanson BS, Ostergren PO, Lindgren A, Sjoberg NO, Marsal K. Association of a lack of psychosocial resources and the risk of giving birth to small for gestational age infants: a stress hypothesis. BJOG. 2000;107(1):89-100.
11. Rondo PH, Ferreira RF, Nogueira F, Ribeiro MC, Lobert H, Artes R. Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. Eur J Clin Nutri. 2003;57(2):266-72.
12. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr. 2003;3:13.
13. Zimmer EZ, Divon MY. Sonographic diagnosis of IUGR-macrosomia. Clin Obstet Gynecol. 1992;35(1):172-84.
14. Banister CE, Koestler DC, Maccani MA, Padbury JF, Houseman EA, Marsit CJ. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics. 2011;6(7):920-7.
15. Ishida M, Moore GE. The role of imprinted genes in humans. Mol Aspect Med. 2012.
16. Takahashi N, Okamoto A, Kobayashi R, Shirai M, Obata Y, Ogawa H, et al. Deletion of Gtl2, imprinted non-coding RNA, with its differentially methylated region induces lethal parent-origin-dependent defects in mice. Human Mol Gen. 2009;18(10):1879-88.
17. Liu Y, Murphy SK, Murtha AP, Fuemmeler BF, Schildkraut J, Huang Z, et al. Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics. 2012;7(7):735-46.
18. Rhode Island Race & Ethnic Origin Demographics by County 2000-2010 - U.S. Bureau of the Census [ http://www.dlt.ri.gov/lmi/census/demo/ethnic.htm ]
19. Friedman JM. Leptin at 14 y of age: an ongoing story. Am J Clin Nutrit. 2009;89(3):973S-9.
20. Lu XY. The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr Opin Pharmacol. 2007;7(6):648-52.
21. Zupancic ML, Mahajan A. Leptin as a neuroactive agent. Psychosom Med. 2011;73(5):407-14.
22. Deuschle M, Blum WF, Englaro P, Schweiger U, Weber B, Pflaum CD, et al. Plasma leptin in depressed patients and healthy controls. Horm Metab Res. 1996;28(12):714-7.
23. Antonijevic IA, Murck H, Frieboes RM, Horn R, Brabant G, Steiger A. Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiat Res. 1998;32(6):403-10.
24. Rubin RT, Rhodes ME, Czambel RK. Sexual diergism of baseline plasma leptin and leptin suppression by arginine vasopressin in major depressives and matched controls. Psychiat Res. 2002;113(3):255-68.
25. Jow GM, Yang TT, Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord. 2006;90(1):21-7.
26. Lawson EA, Miller KK, Blum JI, Meenaghan E, Misra M, Eddy KT, et al. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrin. 2012;76(4):520-5.
27. Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology. 2001;73(4):243-7.
28. Zeman M, Jirak R, Jachymova M, Vecka M, Tvrzicka E, Zak A. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuro Endocrinol Lett. 2009;30(3):387-95.
29. Ren RX, Shen Y. A meta-analysis of relationship between birth weight and cord blood leptin levels in newborns. WJP. 2010;6(4):311-6.
30. Karakosta P, Chatzi L, Plana E, Margioris A, Castanas E, Kogevinas M. Leptin levels in cord blood and anthropometric measures at birth: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2011;25(2):150-63.
31. Lesseur C, Armstrong DA, Paquette AG, Koestler DC, Padbury JF, Marsit CJ. Tissue-specific Leptin promoter DNA methylation is associated with maternal and infant perinatal factors. Mol Cell Endocrinol. 2013;381(1-2):160-7.
32. Struwe E, Berzl GM, Schild RL, Dotsch J. Gene expression of placental hormones regulating energy balance in small for gestational age neonates. Eur J Obstet Gynecol Reprod Biol. 2009;142(1):38-42.
33. Tzschoppe A, Struwe E, Rascher W, Dorr HG, Schild RL, Goecke TW, et al. Intrauterine growth restriction (IUGR) is associated with increased leptin synthesis and binding capability in neonates. Clin Endocrinol (Oxf). 2011;74(4):459-66.
34. Shroff MR, Holzman C, Tian Y, Evans RW, Sikorskii A. Mid-pregnancy maternal leptin levels, birthweight for gestational age and preterm delivery. Clin Endocrinol (Oxf). 2013;78(4):607-13.
35. Catov JM, Patrick TE, Powers RW, Ness RB, Harger G, Roberts JM. Maternal leptin across pregnancy in women with small-for-gestational-age infants. Am J Obstet Gynecol. 2007;196(6):558.
36. Franco-Sena AB, Goldani MZ, Tavares do Carmo M, Velasquez-Melendez G, Kac G. Low leptin concentration in the first gestational trimester is associated with being born small for gestational age: prospective study in Rio de Janeiro. Brazil Neonatology. 2010;97(4):291-8.
37. Mise H, Yura S, Itoh H, Nuamah MA, Takemura M, Sagawa N, et al. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J. 2007;54(6):945-51.
38. Verhaeghe J, van Bree R, Van Herck E. Maternal body size and birth weight: can insulin or adipokines do better? Metabolism: Clin Experimen. 2006;55(3):339-44.
39. Pighetti M, Tommaselli GA, D'Elia A, Di Carlo C, Mariano A, Di Carlo A, et al. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstet Gynecol. 2003;102(3):535-43.
40. Hedley P, Pihl K, Krebs L, Larsen T, Christiansen M. Leptin in first trimester pregnancy serum: no reduction associated with small-for-gestational-age infants. Reprod Biomed Online. 2009;18(6):832-7.
41. Tamura T, Goldenberg RL, Johnston KE, Cliver SP. Serum leptin concentrations during pregnancy and their relationship to fetal growth. Obstet Gynecol. 1998;91(3):389-95.
42. Yildiz L, Avci B, Ingec M. Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. CCLM / FESCC. 2002;40(11):1114-7.
43. Papadopoulou FG, Mamopoulos AM, Triantos A, Constantinidis TC, Papadimas J, Assimakopoulos EA, et al. Leptin levels in maternal and cord serum: relationship with fetal development and placental weight. J Matern Fetal Med. 2000;9(5):298-302.
44. Maymo JL, Perez AP, Gambino Y, Calvo JC, Sanchez-Margalet V, Varone CL. Review: Leptin gene expression in the placenta--regulation of a key hormone in trophoblast proliferation and survival. Placenta. 2011;32 Suppl 2:S146-53.
45. Khalyfa A, Carreras A, Hakim F, Cunningham JM, Wang Y, Gozal D. Effects of late gestational high-fat diet on body weight, metabolic regulation and adipokine expression in offspring. Int J Obes. 2013;37(11):1481-9.
46. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698-709.
47. Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. J Women's Health. 2003;12(4):373-80.
48. Heron J, O'Connor TG, Evans J, Golding J, Glover V. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord. 2004;80(1):65-73.
49. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61-73.
50. de Bie HM, Oostrom KJ, de Waal HA D-v. Brain development, intelligence and cognitive outcome in children born small for gestational age. Horm Res Paediatr. 2010;73(1):6-14.
51. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol. 2006;49(2):257-69.